United Therapeutics says FDA accepts ralinepag NDA
United Therapeutics says the FDA accepted its new drug application for ralinepag to treat pulmonary arterial hypertension and set a PDUFA target action date of June 24, 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
United Therapeutics FDA accepts ralinepag NDA, sets June 24, 2027 PDUFA
United Therapeutics says the FDA accepted its New Drug Application for ralinepag to treat pulmonary arterial hypertension and set a PDUFA date of June 24, 2027.